Heiner Dreismann

Heiner Dreismann

Chairman at MAINZ BIOMED N.V.

Net worth: 3 M $ as of 30/05/2024

69 year
Health Technology
Commercial Services
Health Services

Profile

Dr. Heinrich Dreismann is an Independent Director at Talis Biomedical Corp., a Chairman at Mainz Biomed NV, a Chairman at Biofidelity Ltd., a Senior Independent Non-Executive Director at Congenica Ltd., an Independent Director at Myriad Genetics, Inc., an Advisor at Cambridge Innovation Capital Ltd, a Chairman at Apton Biosystems LLC, a Chairman at MOBILion Systems, Inc., a Member at American Society for Microbiology, a Member at European Diagnostic Manufacturers Association and a Member at New York Academy of Sciences.
He is on the Board of Directors at Inflammatix, Inc., Talis Biomedical Corp., Congenica Ltd., Nucleix Ltd., Spinomix SA, HistoRx, Inc., Myriad Genetics, Inc., Singulex, Inc., BioCision LLC, DNA Script SAS, GestVision, Inc., Many Bright Ideas Technologies, Inc., MedCision LLC and Roche Diagnostics Seattle, Inc. Dr. Dreismann was previously employed as an Independent Director by Interpace Diagnostics Group, Inc., an Independent Director by Ignyta, Inc., an Independent Director by Med BioGene, Inc., a Chief Executive Officer by FasTraq, Inc., a Chief Executive Officer by StageZero Life Sciences Ltd., a Chief Executive Officer by Vectrant Technologies, Inc., a Head-Global Business Development by Roche Diagnostics France SASU, a Head-Manufacturing by F.
Hoffmann-La Roche Ltd., a President & Chief Executive Officer by Roche Molecular Systems, Inc., an Executive Chairman by Homestead Clinical Corp., and a Chairman by Sense Biodetection Ltd.
He also served on the board at Stemina Biomarker Discovery, Inc., AdvanDx, Inc., Adarza BioSystems, Inc., Sirius Genomics, Inc., Shrink Nanotechnologies, Inc., Magellan Diagnostics, Inc., Ngen, Inc., Iconix Biosciences, Inc., BioHelix Corp., Celula, Inc., ChondroGene Ltd., Fore Biotherapeutics, Inc. and Oxford BioDynamics Plc.
He received his graduate degree from the University of Münster and a doctorate degree from the University of Münster.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/06/2024 131,648 ( 0.15% ) 3 M $ 30/05/2024
25/03/2024 88,000 ( 0.40% ) 76 472 $ 30/05/2024
30/01/2024 0 ( -.--% ) - $ 30/05/2024

Heiner Dreismann active positions

CompaniesPositionStart
MYRIAD GENETICS, INC. Director/Board Member 09/06/2010
MAINZ BIOMED N.V. Chairman 13/12/2022
TALIS BIOMEDICAL CORPORATION Director/Board Member 18/05/2023
MANY BRIGHT IDEAS TECHNOLOGIES INC. Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member 31/01/2011
Director/Board Member -
Director/Board Member -
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░ ░ ░░░░░░░ -
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Heiner Dreismann

Former positions of Heiner Dreismann

CompaniesPositionEnd
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Heiner Dreismann's experience

Training of Heiner Dreismann

University of Münster Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Heiner Dreismann's experience

Connections

100 +

1st degree connections

46

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies7
MYRIAD GENETICS, INC.

Health Technology

STAGEZERO LIFE SCIENCES LTD.

Health Technology

MANY BRIGHT IDEAS TECHNOLOGIES INC.

Health Services

OXFORD BIODYNAMICS PLC

Health Technology

INTERPACE BIOSCIENCES, INC.

Health Technology

MAINZ BIOMED N.V.

Health Technology

TALIS BIOMEDICAL CORPORATION

Health Technology

Private companies38
ChondroGene Ltd.

Commercial Services

Health Technology

Health Technology

Health Technology

Health Services

Commercial Services

Health Technology

Vectrant Technologies, Inc.

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Electronic Technology

Electronic Technology

Health Technology

Health Services

Commercial Services

Commercial Services

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Services

European Diagnostic Manufacturers Association

Finance

Health Services

Health Technology

Technology Services

Commercial Services

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Heiner Dreismann